Since increased expression of XPO1 has been related to resistance to chemotherapy and worse prognosis in different neoplasias [23], we studied the potential relationship between expression of XPO1 and sensitivity to selinexor in DLBCL cell lines. This evidence concerns the gene XPO1 and diffuse large B-cell lymphoma.